Press releases

Intrasense presents its innovations at the European Congress of Radiology (ECR) 2024

26 February 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, announces its participation at the ECR from February 28 to March 3, in Vienna (Austria).

See the press release

Intrasense announces the certification of Myrian® to the new European regulation (MDR)

21 February 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, is proud to announce that the company has obtained the new CE certification under MDR (European Union Medical Device Regulation 2017/745), authorizing the marketing of the latest version of its Myrian® solution.

See the press release

Intrasense announces annual revenue for 2023

8 February 2024

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and developer of Myrian® (the "Company"), today announced its 2023 consolidated IFRS revenue (uncertified) at Group level.

See the press release

Intrasense announces its financial agenda for 2024

31 January 2024

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, announces the dates of its next financial communications for the year 2024.

See the press release

Intrasense announces strategic partnership with EDL, French leader in digital healthcare solutions

18 October 2023

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and designer of Myrian®, has announced the signature of a strategic partnership with EDL. French leader in software packages for technical platforms of public and private healthcare establishments, EDL develops Xplore®, a radiology solution. This partnership will enable the integration and marketing of Myrian® clinical applications in the Xplore® suite.

See the press release

2023 Half-year results: sales growth and continued investment policy

20 September 2023

Intrasense (FR0011179886 - ALINS), spécialiste des solutions logicielles d’imagerie médicale et concepteur de Myrian®, annonce ses résultats semestriels 2023 consolidés aux normes IFRS. Etant précisé que suite à l’OPA volontaire du groupe Guerbet, clôturée en date du 5 juin 2023, le groupe Intrasense est maintenant intégré dans le périmètre de consolidation du groupe Guerbet.

See the press release

Intrasense attends the 2023 « Journées Francophones de Radiologie »

13 September 2023

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, announces its attendance in the 2023 “Journées Francophones de la Radiologie” (JFR), where new innovative solutions incorporating artificial intelligence will be presented.

See the press release

Intrasense signs a strategic contract with Ebit to market its solutions in Italy

11 July 2023

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, and Ebit, part of the italian group Esaote, specialized in the development of software solutions for diagnostic imaging, announce their strategic partnership to market Intrasense solutions in Italy.

See the press release

Intrasense and Guerbet sign a licensing and integration agreement for artificial intelligence in oncology medical imaging

19 June 2023

Intrasense (FR0011179886 - ALINS), spécialiste des solutions logicielles d’imagerie médicale et concepteur de Myrian®, et Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announce the signature on June 19, 2023 of a license agreement to integrate and market Guerbet's artificial intelligence algorithms within Intrasense software platforms.

See the press release

Intrasense announces the co-option of a new director and the appointment of a new Chairman of its Board of Directors

25 May 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, annonces, the co-option of a new director to the Board, also appointed Chairman of the Board.

See the press release
1 2 3 11
Subscribe